| Views | |
|---|---|
| Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension | 139 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension | 3 | 4 | 5 | 3 | 2 | 2 | 7 |
| Views | |
|---|---|
| Koklin_Combined.pdf | 87 |
| Views | |
|---|---|
| United States | 49 |
| Canada | 21 |
| Germany | 6 |
| Vietnam | 6 |
| India | 4 |
| China | 2 |
| United Kingdom | 2 |
| Australia | 1 |
| Brazil | 1 |
| Switzerland | 1 |
| Views | |
|---|---|
| Ottawa | 21 |
| Houston | 6 |
| Durham | 4 |
| Fairfield | 4 |
| Hanoi | 3 |
| Mumbai | 3 |
| Palo Alto | 3 |
| San Francisco | 3 |
| Englewood | 2 |
| Mountain View | 2 |